Association of HSD3B1 Genotype With Response to Androgen-Deprivation Therapy for Biochemical Recurrence After Radiotherapy for Localized Prostate Cancer

IMPORTANCE: The variant HSD3B1 (1245C) allele enhances dihydrotestosterone synthesis and predicts resistance to androgen-deprivation therapy (ADT) for biochemically recurrent prostate cancer after prostatectomy and for metastatic disease. Whether this is true after radiotherapy is unknown. OBJECTIVE...

詳細記述

保存先:
書誌詳細
出版年:JAMA Oncol
主要な著者: Hearn, Jason W. D., Xie, Wanling, Nakabayashi, Mari, Almassi, Nima, Reichard, Chad A., Pomerantz, Mark, Kantoff, Philip W., Sharifi, Nima
フォーマット: Artigo
言語:Inglês
出版事項: American Medical Association 2017
主題:
Brief Report
オンライン･アクセス:https://ncbi.nlm.nih.gov/pmc/articles/PMC5933377/
https://ncbi.nlm.nih.gov/pubmed/29049492
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1001/jamaoncol.2017.3164
タグ: タグ追加
タグなし, このレコードへの初めてのタグを付けませんか!

類似資料